MedPath

MVASI 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

MVASI 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

Commercialized
Register Number

1171246002

Prescription Type

Uso Hospitalario

Authorization Date

Sep 27, 2019

Dosage Form

CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1171246002
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
Yes
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

BEVACIZUMABActive
Quantity: 400 mg
Name: BEVACIZUMAB

ATC CLASSIFICATION (3)

L01F
L01FG
L01FG01

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.